M. Hjertman

发表

Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.

G. Nilsson, O. Larsson, L. Kanter, 1999, Glycobiology.

Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules.

M. Brechbiel, L. Abrahmsén, V. Tolmachev, 2008, Bioconjugate chemistry.

Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.

O. Larsson, A. Dricu, J. Wejde, 1997, Glycobiology.

Characterization of hydrophobic prenyl groups of isoprenylated proteins in human cancer cells.

O. Larsson, J. Wejde, M. Hjertman, 2001, Biochemical and biophysical research communications.

Dolichol‐like lipids with stimulatory effect on DNA synthesis: Substrates for protein dolichylation?

O. Larsson, W. Griffiths, J. Wejde, 1998, Journal of cellular biochemistry.

Isoprenoid regulation of cell growth: Identification of mevalonate‐labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate

O. Larsson, J. Wejde, M. Carlberg, 1993, Journal of cellular physiology.

Mevalonic Acid Is Limiting for N-Linked Glycosylation and Translocation of the Insulin-like Growth Factor-1 Receptor to the Cell Surface

O. Larsson, A. Dricu, A. Höög, 1996, The Journal of Biological Chemistry.

Evidence for protein dolichylation

O. Larsson, W. Griffiths, A. Dricu, 1997, FEBS letters.

Analysis of dolichols and polyprenols and their derivatives by electron impact, fast atom bombardment and electrospray ionization tandem mass spectrometry

O. Larsson, W. Griffiths, A. Lundsjö, 1996 .

Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine

Joachim Feldwisch, Vladimir Tolmachev, L. Dinkelborg, 2009, Journal of Nuclear Medicine.